Table 2.
Univariate and multivariate analyses to assess the prognostic factors in propensity score matched 218 gastric cancer patients
| Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | ||
| Gender | female / male | 1.414 | 0.690–3.116 | 0.353 | |||
| Age | < 70 / ≥ 70 | 0.709 | 0.355–1.410 | 0.325 | |||
| pStage | I, II / III | 10.130 | 4.483–27.161 | < 0.001 | 14.003 | 5.033–44.487 | < 0.001 |
| Tumor size | < 5 / ≥ 5 | 2.263 | 1.107–4.977 | 0.025 | 1.735 | 0.718–3.910 | 0.212 |
| PNI | ≥ 44.3 / < 44.3 | 2.000 | 0.999–4.197 | 0.049 | 2.794 | 1.352–6.039 | < 0.001 |
| CEA | < 5.0 / ≥ 5.0 | 2.136 | 1.036–4.254 | 0.040 | 1.821 | 0.878–3.649 | 0.105 |
| Diff. | well & mod / poor | 1.533 | 0.770–3.161 | 0.226 | |||
| BMI | ≥ 18.5 / < 18.5 | 1.052 | 0.414–3.548 | 0.924 | |||
| Adjuvant | No / Yes | 2.528 | 1.268–5.218 | 0.008 | 1.052 | 0.485–2.364 | 0.899 |
HR Hazard ratio, CI Confidence interval, PNI Prognostic nutritional index, CEA Carcinoembryonic antigen, pStage Pathological Stage, Diff Differentiation, BMI Body mass index, Adjuvant adjuvant chemotherapy